Skip to main content
OpenTrials

Clinical trial condition

Drug/Agent Toxicity by Tissue/Organ

Explore clinical trials studying Drug/Agent Toxicity by Tissue/Organ. Study availability and eligibility vary by location and protocol.

30 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Drug/Agent Toxicity by Tissue/Organ trial results

Completed

Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer

NCT00024427

Conditions
Chemically-Induced Disorders, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations
  • Brookwood Medical Center Birmingham, Alabama, United States
  • Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham, Alabama, United States
  • Providence Saint Joseph Medical Center - Burbank Burbank, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View all 29 locations
View Trial Details
Completed

Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer

NCT00245050

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +34 more
Locations
  • Geauga Regional Hospital Cleveland, Ohio, United States
  • Lake/University Ireland Cancer Center Cleveland, Ohio, United States
  • Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Southwest General Health Center Cleveland, Ohio, United States
View Trial Details

Related conditions